These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 3486388

  • 1. The dopamine neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) produces histological lesions in the hypothalamus of the common marmoset.
    Gibb WR, Lees AJ, Jenner P, Marsden CD.
    Neurosci Lett; 1986 Mar 28; 65(1):79-83. PubMed ID: 3486388
    [Abstract] [Full Text] [Related]

  • 2. An immunohistochemical study of the acute and long-term effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the marmoset.
    Waters CM, Hunt SP, Jenner P, Marsden CD.
    Neuroscience; 1987 Dec 28; 23(3):1025-39. PubMed ID: 2893993
    [Abstract] [Full Text] [Related]

  • 3. Chronic administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine to monkeys: behavioural, morphological and biochemical correlates.
    Albanese A, Granata R, Gregori B, Piccardi MP, Colosimo C, Tonali P.
    Neuroscience; 1993 Aug 28; 55(3):823-32. PubMed ID: 8105418
    [Abstract] [Full Text] [Related]

  • 4. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonian syndrome in Macaca fascicularis: which midbrain dopaminergic neurons are lost?
    German DC, Dubach M, Askari S, Speciale SG, Bowden DM.
    Neuroscience; 1988 Jan 28; 24(1):161-74. PubMed ID: 3259295
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the monkey and man.
    Burns RS, Markey SP, Phillips JM, Chiueh CC.
    Can J Neurol Sci; 1984 Feb 28; 11(1 Suppl):166-8. PubMed ID: 6608980
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on ultrastructure of nigral neuromelanin in Macaca fascicularis.
    Levi AC, DeMattei M, Ravazzani R, Corvetti G, Golden GT, Fariello RG.
    Neurosci Lett; 1989 Jan 30; 96(3):271-6. PubMed ID: 2785665
    [Abstract] [Full Text] [Related]

  • 10. Some features of the nigrostriatal dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the mouse.
    Heikkila RE, Sieber BA, Manzino L, Sonsalla PK.
    Mol Chem Neuropathol; 1989 Jun 30; 10(3):171-83. PubMed ID: 2669769
    [No Abstract] [Full Text] [Related]

  • 11. Primate model of parkinsonism: selective lesion of nigrostriatal neurons by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine produces an extrapyramidal syndrome in rhesus monkeys.
    Chiueh CC, Burns RS, Markey SP, Jacobowitz DM, Kopin IJ.
    Life Sci; 1985 Jan 21; 36(3):213-8. PubMed ID: 3871241
    [Abstract] [Full Text] [Related]

  • 12. Hemiparkinsonism in monkeys after unilateral caudate nucleus infusion of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): behavior and histology.
    Imai H, Nakamura T, Endo K, Narabayashi H.
    Brain Res; 1988 Dec 06; 474(2):327-32. PubMed ID: 3264746
    [Abstract] [Full Text] [Related]

  • 13. The evolution and distribution of morphological changes in the nervous system of the common marmoset following the acute administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    Gibb WR, Terruli M, Lees AJ, Jenner P, Marsden CD.
    Mov Disord; 1989 Dec 06; 4(1):53-74. PubMed ID: 2494438
    [Abstract] [Full Text] [Related]

  • 14. Selective loss of subpopulations of ventral mesencephalic dopaminergic neurons in the monkey following exposure to MPTP.
    Schneider JS, Yuwiler A, Markham CH.
    Brain Res; 1987 May 12; 411(1):144-50. PubMed ID: 2886180
    [Abstract] [Full Text] [Related]

  • 15. The significance of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    Marsden CD, Jenner PG.
    Ciba Found Symp; 1987 May 12; 126():239-56. PubMed ID: 3556086
    [Abstract] [Full Text] [Related]

  • 16. Production of a Parkinson-like syndrome in the cat with N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): behavior, histology, and biochemistry.
    Schneider JS, Yuwiler A, Markham CH.
    Exp Neurol; 1986 Feb 12; 91(2):293-307. PubMed ID: 3484707
    [Abstract] [Full Text] [Related]

  • 17. Mechanisms of recovery in MPTP-induced parkinsonism.
    Sandyk R.
    Neuroscience; 1988 Nov 12; 27(2):727-9. PubMed ID: 3146035
    [No Abstract] [Full Text] [Related]

  • 18. Astrocytic responses to the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in cat and mouse brain.
    Schneider JS, Denaro FJ.
    J Neuropathol Exp Neurol; 1988 Jul 12; 47(4):452-8. PubMed ID: 2898510
    [Abstract] [Full Text] [Related]

  • 19. [Mechanism of induction of parkinsonism by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), a dopaminergic neurotoxin].
    Hirata Y, Nagatsu T.
    Tanpakushitsu Kakusan Koso; 1986 Apr 12; 31(5):398-409. PubMed ID: 3520683
    [No Abstract] [Full Text] [Related]

  • 20. Progression and recovery of Parkinsonism in a chronic progressive MPTP-induction model in the marmoset without persistent molecular and cellular damage.
    Franke SK, van Kesteren RE, Wubben JA, Hofman S, Paliukhovich I, van der Schors RC, van Nierop P, Smit AB, Philippens IH.
    Neuroscience; 2016 Jan 15; 312():247-59. PubMed ID: 26431624
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.